The number of hospital discharges for hyperplasia of the prostate in France is projected to gradually decline from 2024 to 2028, starting at 40,610 in 2024 and reducing to 38,460 by 2028. This represents a continuous downward trend with an average yearly decrease of around 0.54%. In 2023, the value stood at a similar level as 2024, indicating the beginning of decline trends in hospital discharges for this condition.
Future trends to watch for include technological advancements in treatment, which may continue to reduce hospital stays and admissions. Additionally, preventive measures and early diagnosis could further mitigate the demand for hospital-based interventions.
